BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

biotech word cloud

8 Major Biopharma Events Coming Later in 2016 and in 2017

Companies in the pharmaceutical industry generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There can be a fair amount of risk ...
Read Full Story »
biotech word cloud

4 BioPharma Movers That Cannot Be Ignored

Over the past week, a few biotech companies made absolutely massive runs, either up and down. In the past year, the health care sector was on fire from positive trials, ...
Read Full Story »
ThinkstockPhotos-481735362

Is BioCryst Reaching Crush Depth?

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) is getting crushed after announcing results from OPuS-2 for the treatment of hereditary angioedema (HAE) attacks. Unfortunately, the company said that this treatment failed to ...
Read Full Story »
refinery

Warren Buffett Continues Massive Energy Insider Buying: Phillips 66, Summit Midstream, Lands’ End and More

Finally after what seems to have been the longest January in recorded investing history, maybe investors are starting to see a light at the end of the tunnel, and it ...
Read Full Story »
French fries

Jefferies Has 5 Top Growth Stocks to Buy After Horrible 2016 Start

Well, last week was lousy, and perhaps some will be recouped this week as the market takes another swing at the upside. One thing's for sure, the massive sell-off last ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

Stocks were pounded lower yet again on Wednesday, but this time on fears of a North Korean hydrogen bomb test. The stock market is off to a rocky start in ...
Read Full Story »
biotech word cloud

4 Key FDA Decisions Expected By Year End

Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount ...
Read Full Story »
Prescription drugs

4 Key FDA Decisions Expected in November and December

Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, as with biotech ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AT&T, BioCryst, Eli Lilly, Facebook, Flextronics, Gap, Tesla and More

Stocks were up yet again on Friday, making for one serious move, with the Dow up about 1,000 points from the lows of just last Friday. Investors have proven over and ...
Read Full Story »
research

BioCryst Upgrade Almost Looks Misunderstood

The most recent analyst call by Merrill Lynch for BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) may be very misunderstood for what it is. The brokerage firm upgraded BioCryst to Neutral and ...
Read Full Story »
biotech

5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015

The health care sector and biotech in particular have been on fire so far in 2015, but some biotech stocks in the group just are not carrying their weight. The ...
Read Full Story »
Ebola Virus

Ebola Finances Coming Back in the News

Within the past week, there has been a resurgence in Ebola-related companies in the news. This doesn’t bring the scare that it did back in the fall, but two of these ...
Read Full Story »
fda_logo

5 Critical Biotech Drug Dates and Events for December

At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks. These events refer to reviews and decisions by the U.S. Food ...
Read Full Story »
Ebola Virus

Ebola Stock Short Interest Surprise

Fears of Ebola seem to have petered out at the end of October and into November. Some of the related stocks had been heavily shorted as they were considered by ...
Read Full Story »
Ebola Virus

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

Just when you thought the Ebola virus outbreak risk was dwindling down... Fresh headlines from Dow Jones and the New York post have put the markets on Ebola watch all ...
Read Full Story »